Splitting Cells: How a Dynamic Protein Machinery Executes ‘the Final Cut’
Released: 9-Jun-2017 4:05 AM EDT
Source Newsroom: Institute of Molecular Biotechnology
Newswise — Previous models proposed that ESCRT-III forms stable filaments that constrict membranes by changing their curvature. However, such static mechanism would be different from most other cellular filament systems, like microtubules or actin filaments, which continuously turn over subunits as they change their shape.
An international research team led by IMBA group leader Daniel Gerlich and Aurélien Roux from the University of Geneva set out to explore for the first time, whether ESCRT-III undergoes dynamic remodeling. To investigate this, the team applied cutting-edge microscopy to visualize the dynamics of ESCRT subunits live in human cells. “We were very excited to find that ESCRT assemblies rapidly turn over their subunits, and that this is orchestrated by an enzyme called VPS4. We discovered that this dynamic turnover removes growth-inhibiting ESCRT-III subunits and thereby stimulates the addition of new subunits. This was surprising, because VPS4 was previously considered to mainly disassemble ESCRT-III filaments, but it actually promotes growth”, explains Beata Mierzwa, PhD student at the Vienna BioCenter and first author of the study.
To study the molecular details of ESCRT-III reorganization, the researchers recapitulated the process in a test tube using purified proteins. They then used high-speed atomic force microscopy to directly visualize dynamically growing and shrinking spiral-shaped filaments. “Our findings provide a new model for how ESCRT-III might deform membrane tubes over large distances, which was difficult to imagine in light of the previous models of persistent filaments. This will be relevant for many other biological processes involving the ESCRT-III machinery.” states Daniel Gerlich.
"Dynamic instability in ESCRT-III assemblies” Beata E. Mierzwa, Nicolas Chiaruttini, Lorena Redondo-Morata, Joachim Moser von Filseck, Julia König, Jorge Larios, Ina Poser, Thomas Müller-Reichert, Simon Scheuring, Aurélien Roux, Daniel W. Gerlich Nature Cell Biology, DOI: 10.1038/ncb3559
IMBA - Institute of Molecular Biotechnology is one of the leading biomedical research institutes in Europe focusing on cutting-edge functional genomics and stem cell technologies. IMBA is located at the Vienna Biocenter, the vibrant cluster of universities, research institutes and biotech companies in Austria. IMBA is a subsidiary of the Austrian Academy of Sciences, the leading national sponsor of non-university academic research.www.imba.oeaw.ac.at
Press pictures: http://de.imba.oeaw.ac.at/index.php?id=516
About the Vienna BioCenter
The Vienna BioCenter (VBC) is a leading life sciences location in Europe, offering an extraordinary combination of research, education and business on a single campus. About 1,600 employees, more than 1,000 students, 93 research groups, 16 biotech companies, and scientists from more than 40 nations create a highly dynamic environment. www.viennabiocenter.org
VBC PhD Programme
Much of the research leading to this publication was carried out by a PhD student of the VBC PhD Programme. Interested in doing a PhD that could be this successful? Then read more on the VBC PhD Programme webpage.